Bristol Myers Squibb, US0897961004

Bristol Myers Squibb stock heads into the open after a 0.7% NYSE gain

Published on 09/15/2026 at 08:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 14, 2026, Bristol Myers Squibb stock finished at USD 64.08 on the NYSE, up 0.69 percent, while trading between USD 63.30 and USD 64.22 and outpacing the S&P 500’s 0.5 percent decline.

Impressionistische Aquarellmalerei der New Yorker Skyline bei Dämmerung, Wolkenkratzer-Silhouetten in weichen Blau- und Bernsteinwaschen mit Lichtreflexionen auf nassen Straßen
Bristol-Myers Squibb US0897961004 Aquarell New Yorker Skyline beleuchtet durch Abenddämmerung mit goldenen Straßenreflexionen, Illustration mit AI erstellt.

Bristol Myers Squibb stock closed at USD 64.08 on the New York Stock Exchange on September 14, 2026, marking a 0.69% gain versus the prior session.

That move came as the shares traded between USD 63.30 and USD 64.22 during the day, with the advance contrasting with a 0.5% decline in the S&P 500 on September 14, 2026.

September 14, 2026 in numbers

Bristol Myers Squibb Inc. (ISIN US0897961004, NYSE: BMY) ended trading on September 14, 2026 at USD 64.08, up 0.69% from the previous close, according to closing data that show a regular-session finish at 3:59 p.m. Eastern Time on the NYSE.

Intraday data for September 14, 2026 indicate that Bristol Myers Squibb shares moved within a day range from USD 63.30 at the low to USD 64.22 at the high, placing the close near the upper end of that band and suggesting steady buying interest through the session.

Per overview figures for the same date, this level kept the stock trading moderately below consensus analyst price targets around the mid-USD 60s, with Ad-hoc-news citing MarketBeat data that placed the consensus price target near USD 66.33 on September 14, 2026.

On the index side, a same-day wrap from Barchart reported that the S&P 500 fell 37.00 points, or 0.5%, to 7,619.98 on September 14, 2026, underscoring that Bristol Myers Squibb’s gain came against a weaker broader market backdrop.

Today’s focus on guidance and macro signals

Looking to today, investors have guidance figures in view after Ad-hoc-news reported on September 14, 2026 that Bristol Myers Squibb’s fiscal 2026 earnings per share guidance stands in a range of USD 6.75 to USD 7.00, while the consensus forecast is around USD 6.95.

That alignment between the company’s outlook and analyst expectations may frame how Bristol Myers Squibb stock trades into today’s session as market participants weigh the shares’ recent outperformance versus the S&P 500 against the room implied by the gap between the current price near USD 64 and the cited consensus target near USD 66.33.

Disclaimer...

en | US0897961004 | BRISTOL MYERS SQUIBB | boerse | 70103896 | bgmi